We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$136B
AUM Growth
+$7.83B
Cap. Flow
+$9.38B
Cap. Flow %
6.92%
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,063
Increased
4,755
Reduced
3,911
Closed
1,116

Sector Composition

Rank Sector Weight
1 Energy 8.49%
2 Technology 6.67%
3 Healthcare 6.67%
4 Financials 6.58%
5 Industrials 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAC icon
5026
Grupo Aeroportuario del Pacifico
PAC
$12.9B
$232K ﹤0.01%
3,441
-3,082
-47% -$214K
LNCO
5027
CALL
DELISTED
LINNCO LLC COM SHS REPSTG LTD LIABILITY
LNCO
$232K ﹤0.01%
8,000
-1,200
-13% -$36.3K
LNCO
5028
PUT
DELISTED
LINNCO LLC COM SHS REPSTG LTD LIABILITY
LNCO
$232K ﹤0.01%
8,000
-5,300
-40% -$160K
BH icon
5029
Biglari Holdings Class B
BH
$1.25B
$231K ﹤0.01%
1,022
+862
+539% +$215K
BLMN icon
5030
Bloomin' Brands
BLMN
$741M
$231K ﹤0.01%
12,543
+9,256
+282% +$170K
NTES icon
5031
CALL
NetEase
NTES
$85.3B
$231K ﹤0.01%
13,500
-405,500
-97% -$6.88M
RGCO icon
5032
RGC Resources
RGCO
$223M
$231K ﹤0.01%
17,432
+1,169
+7% +$15.4K
ARRY
5033
DELISTED
Array Biopharma Inc
ARRY
$231K ﹤0.01%
64,709
-4,083
-6% -$16.1K
PVCT
5034
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$231K ﹤0.01%
226,992
-16,665
-7% -$16.2K
MEAS
5035
DELISTED
MEASUREMENT SPECIALTIES INC
MEAS
$231K ﹤0.01%
2,697
-2,210
-45% -$190K
JUNR
5036
DELISTED
GLOBAL X FDS GLOBAL X JR MINERS ETF
JUNR
$231K ﹤0.01%
+16,884
New +$277K
NGG icon
5037
PUT
National Grid
NGG
$80.4B
$230K ﹤0.01%
3,317
+3,110
+1,502% +$221K
RMBS icon
5038
CALL
Rambus
RMBS
$9.87B
$230K ﹤0.01%
18,400
+200
+1% +$2.52K
SPE
5039
Special Opportunities Fund
SPE
$139M
$230K ﹤0.01%
14,434
-1,053
-7% -$16.9K
AUSE
5040
DELISTED
WisdomTree Australia Dividend Fund
AUSE
$230K ﹤0.01%
4,117
+140
+4% +$8.67K
TAO
5041
DELISTED
Invesco China Real Estate ETF
TAO
$230K ﹤0.01%
11,164
+1,083
+11% +$23.5K
AUXL
5042
PUT
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$230K ﹤0.01%
7,700
+3,700
+93% +$78.4K
DBI icon
5043
PUT
Designer Brands
DBI
$307M
$229K ﹤0.01%
7,600
-2,400
-24% -$68.8K
JHS
5044
John Hancock Income Securities Trust
JHS
$127M
$229K ﹤0.01%
16,261
+1,052
+7% +$15.2K
TLTD icon
5045
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund
TLTD
$668M
$229K ﹤0.01%
3,695
-546
-13% -$35.4K
CFFN icon
5046
Capitol Federal Financial
CFFN
$1.09B
$228K ﹤0.01%
19,323
+7,005
+57% +$84.5K
FFBC icon
5047
First Financial Bancorp
FFBC
$3.55B
$228K ﹤0.01%
14,386
+8,409
+141% +$139K
GPC icon
5048
CALL
Genuine Parts
GPC
$17.1B
$228K ﹤0.01%
2,600
+400
+18% +$34.7K
CLCT
5049
DELISTED
Collectors Universe
CLCT
$228K ﹤0.01%
10,342
+5,510
+114% +$111K
ROST icon
5050
PUT
Ross Stores
ROST
$80.5B
$227K ﹤0.01%
6,000
+200
+3% +$6.96K

Similar funds

UBS's Q3 2014 Portfolio in Review

As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS deployed $9.38B of net new capital in Q3 2014, opening 1,063 new positions and adding to 4,755 existing holdings. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M.

By sector, the portfolio is most concentrated in Energy at 8.5% of assets, down from 8.8% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B trimmed.

  • UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
  • UBS added most to Amgen in Q3 2014, an estimated $387M increase.
  • UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
  • UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
  • UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
  • UBS opened 1,063 new positions and closed 1,116 in Q3 2014.
  • UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.